Based on these novel findings, we posit that changes to RCAN1 levels in the brain throughout aging may perturb light-entrained diurnal and circadian activity, which could in turn contribute to aging-related cognitive impairments and/or AD progression. This evidence concerns the gene RCAN1 and Alzheimer disease.